Pharmaceutical Technology, Nov 1, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Nov 1, 2010
Online Exclusives
Drug Targeting by Diagnostic Ultrasound Contrast
By Steliyan Tinkov , Conrad Coester , Raffi Bekeredjian , Gerhard Winter
Microbubbles can temporarily open many biological barriers for polar molecules, macromolecules, and particles. Scientists have brought well-known contrast agents back to the laboratory and redesigned them as drug carriers. This article is part of a special Drug Delivery issue.
Articles
Sustained-Release Injectable Drug Delivery
By Yun-Seok Rhee , Chun-Woong Park , Patrick P. DeLuca , Heidi M. Mansour
A review on the current status of long-acting injectables, including commercially marketed products. This article is part of a special Drug Delivery issue.
Transdermal Delivery of Vaccines and Therapeutic Proteins
By Kris J. Hansen
The author reviews advances in technology that may soon allow transdermal delivery of two of the fastest growing drug classes on the pharmaceutical market. This article is part of a special Drug Delivery issue.
Considerations and Approaches for Filling Dry-Powder Inhalers
By Craig J. Davies Cutting
The author reviews key considerations for formulating powders for use in inhalers. This article is part of a special Drug Delivery issue.
Capsule-in-Capsule Technology
By W.J. Bowtle
The author outlines how to choose carriers and capsule shells according to dosage requirements and intended use. This article is part of a special Drug Delivery issue.
Melt Extrusion: Shaping Drug Delivery in the 21st Century
By James C. DiNunzio , Charlie Martin , Feng Zhang
The authors provde a review of melt extrusion's evolution and applications in the pharmaceutical industry. This article is part of a special Drug Delivery issue.
Minitablets Coated in a Solid-Wall Pan for Theophylline Sustained-Release Capsules
By Caterina Funaro , Giusi Mondelli , Nadia Passerini , Beatrice Albertini
The authors describe an alternative approach to compressing and coating minitablets for use in a sustained-release, solid oral-dosage form. This article is part of a special Drug Delivery issue.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
25%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
11%
Regulatory compliance
36%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here